Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aid Genomics

Aid Genomics
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of molecular diagnostic technologies designed to elucidate the genetic DNA profile of different patients and assist physicians in selecting safe and effective treatments tailored to each patient's genetic profile. The company's molecular diagnostics services focuses on integrating molecular genomics with personalized therapeutic approaches offering gene-based diagnostics for personalized medicine to treat various cancers and other hereditary diseases.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Primary Office
  • 4th Hasadnaot Street
  • Herzliya
  • Israel

+972 000-000-0000

Aid Genomics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Aid Genomics‘s full profile, request access.

Request full access to PitchBook

Aid Genomics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Aid Genomics‘s full profile, request access.

Request full access to PitchBook

Aid Genomics Executive Team (6)

Name Title Board
Seat
Contact
Info
Gil Pogozelich Ph.D Chief Executive Officer and Chairman
Monica Wolmer Chief Financial Officer
Ayala Lagziel Ph.D Chief Technology Officer
Izhak Haviv Chief Scientific Officer
Ariel Rinon Director, Marketing & Business Development

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

Aid Genomics Board Members (1)

Name Representing Role Since Contact
Info
000 0000000000 00.0 Aid Genomics Chief Executive Officer and Chairman 000 0000